Neuphoria Therapeutics Stock Forecast - Naive Prediction

NEUP Stock   4.11  0.01  0.24%   
The Naive Prediction forecasted value of Neuphoria Therapeutics on the next trading day is expected to be 4.05 with a mean absolute deviation of 0.15 and the sum of the absolute errors of 9.40. Neuphoria Stock Forecast is based on your current time horizon. Although Neuphoria Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Neuphoria Therapeutics' systematic risk associated with finding meaningful patterns of Neuphoria Therapeutics fundamentals over time.
As of today the rsi of Neuphoria Therapeutics' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Neuphoria Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Neuphoria Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Neuphoria Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(1.31)
EPS Estimate Current Year
(4.07)
EPS Estimate Next Year
(3.85)
Wall Street Target Price
9.7667
Using Neuphoria Therapeutics hype-based prediction, you can estimate the value of Neuphoria Therapeutics from the perspective of Neuphoria Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Neuphoria Therapeutics on the next trading day is expected to be 4.05 with a mean absolute deviation of 0.15 and the sum of the absolute errors of 9.40.

Neuphoria Therapeutics after-hype prediction price

    
  USD 4.12  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Neuphoria Therapeutics to cross-verify your projections.
To learn how to invest in Neuphoria Stock, please use our How to Invest in Neuphoria Therapeutics guide.As of 01/19/2026, Inventory Turnover is likely to drop to 16.79. In addition to that, Payables Turnover is likely to drop to 0.001. As of 01/19/2026, Common Stock Shares Outstanding is likely to drop to about 1.8 M.

Neuphoria Therapeutics Additional Predictive Modules

Most predictive techniques to examine Neuphoria price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Neuphoria using various technical indicators. When you analyze Neuphoria charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Neuphoria Therapeutics Cash Forecast

Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Neuphoria Therapeutics' financial statements to estimate their effects on upcoming price movements.
 
Cash  
First Reported
2001-06-30
Previous Quarter
14.2 B
Current Value
13.6 M
Quarterly Volatility
1.7 B
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
A naive forecasting model for Neuphoria Therapeutics is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Neuphoria Therapeutics value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Neuphoria Therapeutics Naive Prediction Price Forecast For the 20th of January

Given 90 days horizon, the Naive Prediction forecasted value of Neuphoria Therapeutics on the next trading day is expected to be 4.05 with a mean absolute deviation of 0.15, mean absolute percentage error of 0.07, and the sum of the absolute errors of 9.40.
Please note that although there have been many attempts to predict Neuphoria Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Neuphoria Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Neuphoria Therapeutics Stock Forecast Pattern

Backtest Neuphoria TherapeuticsNeuphoria Therapeutics Price PredictionBuy or Sell Advice 

Neuphoria Therapeutics Forecasted Value

In the context of forecasting Neuphoria Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Neuphoria Therapeutics' downside and upside margins for the forecasting period are 0.04 and 12.86, respectively. We have considered Neuphoria Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
4.11
4.05
Expected Value
12.86
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Neuphoria Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Neuphoria Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria115.4799
BiasArithmetic mean of the errors None
MADMean absolute deviation0.1541
MAPEMean absolute percentage error0.0341
SAESum of the absolute errors9.3994
This model is not at all useful as a medium-long range forecasting tool of Neuphoria Therapeutics. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Neuphoria Therapeutics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Neuphoria Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Neuphoria Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neuphoria Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.214.1213.00
Details
Intrinsic
Valuation
LowRealHigh
0.275.4514.33
Details
2 Analysts
Consensus
LowTargetHigh
8.899.7710.84
Details

Other Forecasting Options for Neuphoria Therapeutics

For every potential investor in Neuphoria, whether a beginner or expert, Neuphoria Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Neuphoria Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Neuphoria. Basic forecasting techniques help filter out the noise by identifying Neuphoria Therapeutics' price trends.

Neuphoria Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neuphoria Therapeutics stock to make a market-neutral strategy. Peer analysis of Neuphoria Therapeutics could also be used in its relative valuation, which is a method of valuing Neuphoria Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Neuphoria Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Neuphoria Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Neuphoria Therapeutics' current price.

Neuphoria Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Neuphoria Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neuphoria Therapeutics shares will generate the highest return on investment. By undertsting and applying Neuphoria Therapeutics stock market strength indicators, traders can identify Neuphoria Therapeutics entry and exit signals to maximize returns.

Neuphoria Therapeutics Risk Indicators

The analysis of Neuphoria Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Neuphoria Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neuphoria stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Neuphoria Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Neuphoria Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuphoria Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Neuphoria Stock

  0.76RAC Race OncologyPairCorr

Moving against Neuphoria Stock

  0.48VCYT VeracytePairCorr
  0.4VCEL Vericel Corp OrdPairCorr
  0.32DMAC DiaMedica TherapeuticsPairCorr
  0.31DNTH Dianthus TherapeuticsPairCorr
The ability to find closely correlated positions to Neuphoria Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Neuphoria Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Neuphoria Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Neuphoria Therapeutics to buy it.
The correlation of Neuphoria Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Neuphoria Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Neuphoria Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Neuphoria Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Neuphoria Stock Analysis

When running Neuphoria Therapeutics' price analysis, check to measure Neuphoria Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuphoria Therapeutics is operating at the current time. Most of Neuphoria Therapeutics' value examination focuses on studying past and present price action to predict the probability of Neuphoria Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuphoria Therapeutics' price. Additionally, you may evaluate how the addition of Neuphoria Therapeutics to your portfolios can decrease your overall portfolio volatility.